Scientific Communications Strategy

Senior-level scientific communications
strategy and execution for
high-stakes medical communications projects.

I help medical affairs and high-science commercial teams move faster on complex deliverables — without agency layers, junior handoffs, or unnecessary overhead.

Let's discuss a project
~20 Years in pharma & biotech communications
PhD Scientific credibility
1 Senior lead, strategy through execution

Four engagement models.
One accountable partner.

From urgent deck rescues to full scientific platform development — built around your timeline, your science, your review cycle.

01

High-Stakes Scientific Deliverables

Flagship communications built to hold up under scrutiny — at congress, in the boardroom, or through MLR. Senior thinking, from the first slide to final approval.

Speaker Decks Congress Symposia Executive Narratives MLR-Ready Materials

02

Scientific Narrative & Asset Strategy

Build the backbone that everything else can connect to. Scientific platform development, evidence narrative architecture, and downstream translation into field and speaker assets.

Scientific Platform Evidence Narrative Publication Planning Field Asset Translation

03

Advisory Board & Congress Support

Strategic advisory design with rigorous follow-through — from objectives and moderator guides to post-meeting synthesis and insight-to-action recommendations.

Agenda & Objectives Moderator Guides Pre-Read Materials Post-Meeting Synthesis

04

Rapid Response Support

When a deck is broken, the timeline is already short, and the agency can't move fast enough. Urgent turnaround, strategic reframing, and high-visibility project rescue.

Deck Rescue Strategic Reframe Urgent Turnaround
LMS

The moments that define a program.

These are the high-stakes situations where senior judgment, scientific rigor, and fast execution need to exist in the same person.

Your team is doing the thinking twice

Strategy handed to execution. Execution handed back to review. Senior intent gets diluted at every pass. I keep the thinking connected from first conversation to final deliverable.

The timeline doesn't fit the agency model

Three rounds of kickoffs and a rotating account team won't get you there. You need someone who already understands the science and can move on day one.

This needs to hold up under review

MLR isn't just a formatting exercise. When scientific accuracy, regulatory language, and strategic clarity all need to coexist, you need someone who can defend every word.

Medical affairs and commercial need to align

Different audiences, different norms, same science. I've worked across both sides and can bridge the gap without losing rigor or diluting the message.

Big-agency caliber thinking.
Independent-consultant speed.

One senior accountable lead from strategy through execution. No junior handoffs. No layers between the thinking and the build.

"I built this model for the teams I used to work alongside — the ones who needed senior thinking and hands-on execution in the same person, on the same day."

  • 01

    No junior handoffs

    The person you brief is the person who does the work. Your strategic context stays intact from kickoff through delivery.

  • 02

    Fewer layers, faster decisions

    Questions get answered directly. Revisions happen in real time. No account management layer between science and execution.

  • 03

    Built for review-readiness

    Every deliverable is developed with MLR and scientific scrutiny in mind — not retrofitted for compliance after the creative work is done.

  • 04

    AI-enabled, human-led

    Modern AI tools extend my capacity without compromising scientific judgment. Faster drafts. Sharper synthesis. The thinking is always mine.

  • 05

    Fixed-fee, project-based

    Clear scope. Clear deliverable. Clear cost. No surprise billings when the project evolves, no hourly anxiety on your end.

The LMS Model

Senior judgment +
direct execution +
AI-enabled efficiency

Traditional agency LMS
Account team Direct access
Junior writers Senior execution
Multiple handoffs One owner
Slow iteration Real-time revision
Hourly billing Fixed-fee projects
Diluted strategy Strategy to delivery

The asset is the person.

I've spent nearly twenty years in pharmaceutical and biotechnology communications — first building programs inside agencies, then leading them, and eventually working alongside the client teams who needed them most.

My scientific background (PhD) grounds everything I do. I can engage directly with the data, translate complexity for any audience, and hold my own in conversations with medical directors, KOLs, and regulatory reviewers. That credibility doesn't disappear when the work gets strategic — it makes the strategy better.

I've worked across a wide range of therapeutic areas — from rare disease to large-volume specialty — and across the full range of medical communications touchpoints: advisory boards, congress symposia, publications, field tools, and executive presentations. I understand both the medical affairs world and the commercial scientific communications world, and the careful navigation required between them.

LMS exists because the teams I worked with kept describing the same gap: they had access to big agencies with big processes, or independent contractors without the strategic depth. They needed something in between — senior thinking and hands-on execution in the same engagement.

"I built this consultancy for teams that need senior-level thinking and hands-on execution in the same person — at the moment they need it most."
Mike Lieberman

Mike Lieberman

Founder, LMS Scientific Communications

linkedin.com/in/mlieberman

Credentials & Depth

  • ~20 years in pharma & biotech communications
  • PhD — scientific credibility across complex therapeutic areas
  • Agency leadership experience
  • Client-side (in-house) experience
  • Medical affairs and commercial scientific communication
  • Therapeutic breadth: rare disease, oncology, specialty, and beyond
  • MLR-experienced across multiple organizations
  • Advisory board design and execution
  • Congress and symposia development
  • KOL and executive-level communication

Let's discuss a project.

Tell me what you're working on — even if it's early or unclear, a brief conversation is often enough to know if there's a fit.

Response time

I respond to all inquiries within one business day. For urgent projects, note that in your message.

Who I work with

Biotech and pharma companies, medical affairs teams, commercial scientific groups, and cross-functional leads managing high-stakes scientific communications moments.

Every engagement starts with a direct conversation — no intake forms, no scoping decks. Just a clear discussion about what you need and whether this model is the right fit.